BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 26305602)

  • 1. Overexpression of Fli-1 is associated with adverse prognosis of endometrial cancer.
    Song W; Zhang T; Li W; Mu R; Zhang L; Li Y; Jin B; Wang N; Li A; Cui J
    Cancer Invest; 2015; 33(9):469-75. PubMed ID: 26305602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
    Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP
    Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of Sam68 expression in endometrial carcinoma.
    Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
    Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer.
    Bian Y; Chang X; Liao Y; Wang J; Li Y; Wang K; Wan X
    Oncol Rep; 2016 Aug; 36(2):803-10. PubMed ID: 27373314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy.
    Sakurai T; Kondoh N; Arai M; Hamada J; Yamada T; Kihara-Negishi F; Izawa T; Ohno H; Yamamoto M; Oikawa T
    Cancer Sci; 2007; 98(11):1775-84. PubMed ID: 17727680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Fli-1 in astrocytoma is associated with poor prognosis.
    Tsai HP; Tsai TH; Hsieh YJ; Chen YT; Lee CL; Tsai YC; She TC; Lin CL; Chai CY; Kwan AL
    Oncotarget; 2017 Apr; 8(17):29174-29186. PubMed ID: 28418872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
    Chen H; Wang Y; Xue F
    Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer.
    Song W; Hu L; Li W; Wang G; Li Y; Yan L; Li A; Cui J
    BMC Cancer; 2014 Jun; 14():424. PubMed ID: 24923303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.
    Cui JW; Vecchiarelli-Federico LM; Li YJ; Wang GJ; Ben-David Y
    Leukemia; 2009 Jul; 23(7):1311-9. PubMed ID: 19282832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M activates STAT3 to promote endometrial cancer invasion and angiogenesis.
    Zhu M; Che Q; Liao Y; Wang H; Wang J; Chen Z; Wang F; Dai C; Wan X
    Oncol Rep; 2015 Jul; 34(1):129-38. PubMed ID: 25954856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34c plays a role of tumor suppressor in HEC‑1-B cells by targeting E2F3 protein.
    Li F; Chen H; Huang Y; Zhang Q; Xue J; Liu Z; Zheng F
    Oncol Rep; 2015 Jun; 33(6):3069-74. PubMed ID: 25846116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific siRNA inhibits XIAP expression in human endometrial carcinoma cell apoptosis.
    Yin D; Wang N; Zhang SL; Jiang Y; Lu YM; Wei H; Huo NC; Xiao Q; Ou YL
    Cell Biochem Biophys; 2015 Jan; 71(1):161-5. PubMed ID: 25151142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
    Vaskivuo TE; Stenbäck F; Tapanainen JS
    Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer.
    Iwadate R; Inoue J; Tsuda H; Takano M; Furuya K; Hirasawa A; Aoki D; Inazawa J
    Am J Pathol; 2015 Sep; 185(9):2523-33. PubMed ID: 26162509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.
    Semczuk A; Marzec B; Skomra D; Roessner A; Cybulski M; Rechberger T; Schneider-Stock R
    Oncology; 2005; 69(4):317-25. PubMed ID: 16293976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathological significance of TMEFF2, SMOC-2, and SOX17 expression in endometrial carcinoma.
    Alabiad MA; Harb OA; Hefzi N; Ahmed RZ; Osman G; Shalaby AM; Alnemr AA; Saraya YS
    Exp Mol Pathol; 2021 Oct; 122():104670. PubMed ID: 34339705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis.
    Lin L; Zheng X; Qiu C; Dongol S; Lv Q; Jiang J; Kong B; Wang C
    Oncol Rep; 2014 Dec; 32(6):2831-5. PubMed ID: 25270091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
    Soufla G; Sifakis S; Spandidos DA
    Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.